|Day Low/High||4.54 / 4.69|
|52 Wk Low/High||3.12 / 7.24|
The New Dietary Supplement Protects Against Oxidative Stress and Promotes Healthy Aging
ChromaDex Will Use Proprietary Suntava(R) Purple Corn to Produce a Highly Concentrated Anthocyanin Ingredient at a Price Point That Should Appeal to Mass Markets
- Total Q1 Revenue Grew 71% to $5.3 Million as Company Reports 4th Consecutive Quarter of Record Net Revenue -
Company Will Release First Quarter Earnings Report After Market Close on May 14th
ChromaDex Holds Exclusive Worldwide Patent Rights Related to Pharmaceutical and Cosmetic Preparations of Pterostilbene for Topical Application
The top 10 open-market insider purchases and sales filed at the SEC Thursday.
Standard & Poor’s announced today that it has commenced Factual Stock Report coverage on ChromaDex Corporation.
DiscoveryBioMed, Inc. (DBM) today announced that it has been awarded a $200,000 Small Business Innovations Research (SBIR) Phase 1 grant by the National Institutes of Health (NIH) to continue research into the ...
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.